๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT ยท Real-Time Price ยท USD
9.95
-0.62 (-5.87%)
At close: Nov 20, 2026, 4:00 PM EST
10.07
+0.12 (1.21%)
After-hours: Nov 20, 2026, 7:54 PM EST

Summit Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.711.81
Revenue Growth
-----61.03%110.35%
Gross Profit
----0.711.81
Operating Income
-855.24-1,094-210.99-88.74-63.62-86.19
Net Income
-832.68-1,080-221.32-614.93-78.78-88.6
Earnings Per Share
-1.07-1.44-0.31-0.99-0.41-0.96
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
629.79713.45412.35186.24348.6171.79
Total Debt
19.9820.897.22106.1518.762.78
Net Cash (Debt)
609.81692.56405.1380.14-170.1669.01
Net Cash Growth
161.58%70.95%405.51%--4.63%
Net Cash Per Share
0.780.930.560.13-0.880.75

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-525.17-322.93-142.11-76.76-41.58-72.59
Capital Expenditures
-1.71-0.66-0.14-0.13-0.62-0.31
Free Cash Flow
-526.88-323.59-142.25-76.89-42.21-72.89
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----9024.25%-4764.29%
Pretax Margin
-----11174.75%-4897.84%
Profit Margin
-----11174.75%-4897.84%
FCF Margin
-----5986.67%-4029.46%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----1272.24145.30